Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elle, MD Biotechnologies is a private Canadian femtech/biotechnology company developing a hormone-free contraceptive product for women’s reproductive health. Its lead product, The Better Ring, is a copper-based, user-controlled vaginal contraceptive device designed to prevent pregnancy without systemic hormones and with plans for a second indication in emergency contraception. The company positions the product as reusable, reversible, and female-controlled, aiming to improve efficacy, tolerability, and autonomy relative to existing options. Founded by physician Jennifer Johnston and based in Nova Scotia, the company is focused on expanding contraceptive choice and access, particularly for women seeking non-hormonal alternatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ELLE.